17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Purpose to evaluate the effects of intramuscular 17-Alpha-Hydroxyprogesterone Caproate
(17-OHPC) for prevention of Emergent Cesarean Delivery in symptomatic Pregnant Women with
Placenta Previa